| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |